Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475760 | 0.89 | KDM4E (0.56) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL165562 | 0.83 | KDM4E (0.51) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL7868931 | 0.83 | KDM4E (0.51) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL3446204 | 0.83 | CA12 (0.58) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL12180307 | 0.83 | L3MBTL1 (0.51) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL3595760 | 0.82 | L3MBTL1 (0.51) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL17113062 | 0.82 | CA12 (0.46) | KDM4EL3MBTL1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL3446852 | 0.82 | L3MBTL1 (0.50) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL3511987 | 0.81 | LOXL2 (0.49) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL5159229 | 0.80 | KMT2A (0.38) | KDM4EL3MBTL1ALDH1A1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816387-B2 | β secretase inhibitor | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-7816387-B2 | β secretase inhibitor | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2010-10-19 | — | — | US | disclosed |
| EP-1562897-B1 | PHENYLCARBOXAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE | MERCK & CO INC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090198056-A1 | Beta secretase inhibitor | KISO, YOSHIAKI (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090198056-A1 | Beta secretase inhibitor | KISO, YOSHIAKI (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-1942101-A1 | SECRETASE INHIBITOR | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1942101-A1 | SECRETASE INHIBITOR | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2008-07-09 | — | — | EP | disclosed |
| US-7348356-B2 | Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease | MERCK & CO., INC. (US) | 2008-03-25 | — | — | US | disclosed |
| US-7348356-B2 | Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease | MERCK & CO., INC. (US) | 2008-03-25 | — | — | US | disclosed |
| US-7348448-B2 | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | MERCK & CO., INC. (US) | 2008-03-25 | — | — | US | disclosed |
| US-7348448-B2 | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | MERCK & CO., INC. (US) | 2008-03-25 | — | — | US | disclosed |
| WO-2005004803-A2 | PHENYLCARBOXYLATE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| WO-2004043916-A1 | PHENYLCARBOXAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2004-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090198056-A1 | Beta secretase inhibitor | BACE1, BACE2, APP | KDM4E 1815/4885L3MBTL1 1012/4885ALDH1A1 2130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.